This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: University of Rochester, Fred Hutchinson Cancer Center, Leiden University Medical Center. Active years: 2020-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2020-2026
Title: Silvere M Van Der Maarel: Innovator in Genetic Research
Introduction
Silvere M Van Der Maarel is a notable inventor based in Leiden, Netherlands. He has made significant contributions to the field of genetic research, particularly in understanding and addressing Facioscapulohumeral Dystrophy (FSHD). His innovative work has led to the development of a patent that offers new methods for screening genetic predispositions to this condition.
Latest Patents
Van Der Maarel holds a patent titled "Methods for alleviating facioscapulohumeral dystrophy (FSHD) by N siRNA molecule inhibiting the expression of DUX4-FL." This patent outlines a method for screening human subjects to determine their genetic predisposition to FSHD. The process involves analyzing genomic DNA from a biological sample to identify specific polymorphisms linked to the DUX4 gene. The findings can indicate whether a subject is at risk of developing or is currently suffering from FSHD.
Career Highlights
Throughout his career, Silvere M Van Der Maarel has worked with prestigious institutions such as the Fred Hutchinson Cancer Research Center and the University of Rochester. His research has focused on genetic disorders, contributing to advancements in understanding and potentially treating these conditions.
Collaborations
Van Der Maarel has collaborated with esteemed colleagues in the field, including Stephen J Tapscott and Rabi Tawil. These partnerships have enhanced the depth and impact of his research, fostering a collaborative environment for innovation.
Conclusion
Silvere M Van Der Maarel's contributions to genetic research, particularly in relation to FSHD, highlight his role as an influential inventor. His patent and collaborative efforts continue to pave the way for advancements in understanding genetic predispositions and potential treatments for this condition.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile